MedPath

Effects of clonidine in children during electroencephalography

Phase 2
Conditions
Epilepsy.
Epilepsy
Registration Number
IRCT2016102118946N5
Lead Sponsor
Vice Chancellor for Research, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
45
Inclusion Criteria

age between 2 and 12 years old; history of epilepsy; history of failure to sedation with other routine medications than clonidine.
Exclusion criteria: cardiovascular disease; gastrointestinal disease; pulmonary disease; renal disease; hemodynamic instability.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Consciousness. Timepoint: Before intervention- continuously after intervention until complete consciousness. Method of measurement: Assessing by physician.
Secondary Outcome Measures
NameTimeMethod
Heart rate. Timepoint: Before intervention- 2 hours after intervention. Method of measurement: Assessing by physician.;Respiratory rate. Timepoint: Before intervention- 2 hours after intervention. Method of measurement: Assessing by physician.;Blood pressure. Timepoint: Before intervention- 2 hours after intervention. Method of measurement: Assessing by physician.;Body tempreture. Timepoint: Before intervention- 2 hours after intervention. Method of measurement: Assessed using thermometer.;Blood oxygen saturation. Timepoint: Before intervention- 2 hours after intervention. Method of measurement: Assessed using pulsoximetry.
© Copyright 2025. All Rights Reserved by MedPath